EUVIMEDEUVIMED entdecken
Crossref

SGLT2 inhibitors activate pantothenate kinase in the human heart

Nicholas Forelli iD, Trace Thome iD, Deborah M Eaton iD, Kollin Schultz iD, Jiten Patel iD, Caitlyn E Bowman iD, Ryo Kawakami iD, Jae Woo Jung iD, Ivan A Kuznetsov, Kristina Li iD, Jialiu A Liang iD, Kirsten Branch und 17 weitere

Science · 27.08.2026 · 393 (6814) · 895-902

DOI: 10.1126/science.aeh4856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 27.08.2026. Verfasst von Nicholas Forelli und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Coenzyme A, Myocardium, Myocytes, Cardiac, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institutes of Health, Fondation Leducq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce mortality in heart failure, but their pharmacological target remains unclear. In this study, we showed that SGLT2i directly activate pantothenate kinase 1 (PANK1), the rate-limiting enzyme in coenzyme A (CoA) synthesis. Using stable isotope infusions, we established that SGLT2i activate CoA synthesis and broadly stimulate fuel use in human cardiac tissue. We also demonstrated that SGLT2i bind PANK1 at physiological concentrations, directly inducing conformational changes and increasing enzymatic activity. In silico modeling identified the site of SGLT2i binding on PANK1, which was confirmed by amino acid mutagenesis. Finally, we showed that SGLT2i-mediated PANK activation is necessary and sufficient to increase contractility of human cardiomyocytes. In summary, we demonstrate off-target activation of PANK1 and promotion of CoA synthesis by SGLT2i, which may explain their marked clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coenzyme AMyocardiumMyocytes, CardiacPhosphotransferases (Alcohol Group Acceptor)Sodium-Glucose Transporter 2 InhibitorsMuscle ContractionHumansBinding SitesEnzyme ActivationProtein Conformation

Substanzen

Coenzyme Apantothenate kinasePhosphotransferases (Alcohol Group Acceptor)Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Aging and Cardiovascular Discovery Center, Department of Cardiovascular Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Cardiology, Cardiovascular Institute, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Nicholas Forelli, Trace Thome, Deborah M Eaton, Kollin Schultz, Jiten Patel, Caitlyn E Bowman, Ryo Kawakami, Jae Woo Jung, Kristina Li, Jialiu A Liang, Claire Brady, Kenneth C Bedi, Yijun Yang, Kaustubh Koya, Daniel S Kantner, Louis G Smith, Cristin F MacIntosh, Edwin Yoo, Simone Sidoli, Kushol Gupta, Gregory R Bowman, Nathaniel W Snyder, Jonathan Edwards, Kenneth B Margulies, Zoltan Arany

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • Fondation Leducq
  • Dream Team, CVI, University of Pennsylvania
  • Sarnoff Foundation

Zitieren

APA

Forelli, N., Thome, T., Eaton, D. M., Schultz, K., Patel, J., Bowman, C. E., Kawakami, R., Jung, J. W., Kuznetsov, I. A., Li, K., Liang, J. A., Branch, K., Brady, C., Bedi, K. C., Yang, Y., Koya, K., Bouhrira, N., Megill, E., Kantner, D. S., …, & Arany, Z. (2026). SGLT2 inhibitors activate pantothenate kinase in the human heart. Science, 393(6814), 895-902. https://doi.org/10.1126/science.aeh4856

Vancouver

Forelli N, Thome T, Eaton DM, Schultz K, Patel J, Bowman CE, et al. SGLT2 inhibitors activate pantothenate kinase in the human heart. Science. 2026;393(6814):895-902. doi:10.1126/science.aeh4856

BibTeX
@article{Forelli2026,
  author = {Forelli, Nicholas and Thome, Trace and Eaton, Deborah M and Schultz, Kollin and Patel, Jiten and Bowman, Caitlyn E and Kawakami, Ryo and Jung, Jae Woo and Kuznetsov, Ivan A and Li, Kristina and Liang, Jialiu A and Branch, Kirsten and Brady, Claire and Bedi, Kenneth C and Yang, Yijun and Koya, Kaustubh and Bouhrira, Nesrine and Megill, Emily and Kantner, Daniel S and Smith, Louis G and MacIntosh, Cristin F and Yoo, Edwin and Sidoli, Simone and Gupta, Kushol and Bowman, Gregory R and Snyder, Nathaniel W and Edwards, Jonathan and Margulies, Kenneth B and Arany, Zoltan},
  title = {SGLT2 inhibitors activate pantothenate kinase in the human heart},
  journal = {Science},
  year = {2026},
  volume = {393},
  number = {6814},
  pages = {895--902},
  doi = {10.1126/science.aeh4856}
}
Kostenlos starten →